© 2001 American Heart Association, Inc.
Atherosclerosis and Lipoproteins |
Localization of Human ATP-Binding Cassette Transporter 1 (ABC1) in Normal and Atherosclerotic Tissues
From The Winship Cancer Institute (T.L.C., J.N.W.), Division of Hematology/Oncology, Emory University School of Medicine, Atlanta, Ga, and CV Therapeutics, Inc (R.M.L., D.P.W.), Palo Alto, Calif.
Correspondence to Josiah N. Wilcox, PhD, Emory University, The Winship Cancer Institute, Division of Hematology/Oncology, 1639 Pierce Dr, Room 1115 WMRB, Atlanta, GA 30322. E-mail medjnw{at}emory.edu
 |
Abstract |
|---|
 Top Abstract IntroductionMethodsResultsDiscussionReferences |
|---|
Abstract—The present study examines the expression of ATP-binding cassette transporter 1 (ABC1) mRNA in normal and atherosclerotic tissues by using in situ hybridization in an effort to better understand the function of this cholesterol transport protein. Samples of normal baboon tissues as well as human normal and atherosclerotic aortas were hybridized with 35S-labeled ABC1 sense and antisense riboprobes. Widespread expression of ABC1 was observed generally in tissues containing inflammatory cells and lymphocytes. Other noninflammatory cells that were also sites of ABC1 synthesis included the ductal cells of the kidney medulla, Leydig cells in the testis, and glial cells in the baboon cerebellum. Although normal veins and arteries did not express ABC1 mRNA, it was found to be upregulated in the setting of atherosclerosis, where widespread expression was found in macrophages within atherosclerotic lesions. These results are consistent with the proposed role of ABC1 in cholesterol transport in inflammatory cells. The specific upregulation of ABC1 mRNA in the setting of atherosclerosis probably reflects the response of leukocytes to cholesterol loading. However, the presence of ABC1 in ductal cells of the kidney medulla and in the small intestine suggest a more general role for this protein in cholesterol transport in other cell types.
Key Words: HDL • cholesterol • atherosclerosis • ATP-binding cassette transporter 1 (ABC1) • ATB-binding cassette transporter A1 (ABCA1)
|
Introduction |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Low plasma HDL concentration is a major risk factor for cardiovascular disease, yet the mechanisms that control the flux of cholesterol through HDL transport in plasma remain poorly understood. The biochemical understanding of this pathway was enhanced by the identification of ATP-binding cassette transporter 1 (ABC1, also known as ABCA1), an ATP-dependent sterol transporter, as the genetic defect in Tangier disease, a monogenic disorder marked by near-zero levels of circulating HDL.1 2 3 4 ABC1 is a member of the family of ATP-binding cassette proteins that transport ligands across the plasma membrane. This family includes the cystic fibrosis transporter (CFTR), several multidrug resistance P glycoproteins, and the ocular protein ABC-R.5 Intracellular roles are also likely for some of the ABC proteins. Ever since its identification as the defective gene in Tangier disease, most investigations have focused on the role of ABC1 in apolipoprotein-mediated efflux of cholesterol and phospholipids from macrophages. To date, cell culture studies using inhibition and overexpression suggest that ABC1 may play a rate-limiting step in that process.4 6 Similarly, the intermediate levels of HDL in humans and knockout mice heterozygous for ABC1 gene deficiency suggest that ABC1 is a vital determinant of plasma HDL concentration.7 8 9 Because a hallmark of Tangier disease is massive cholesterol deposition in tissue macrophages, the initial focus on this cell type seems justified.10 However, ABC1 message has been detected in various tissues, including liver, lung, adrenals, small intestine, and brain.11
Because tissue macrophages may not represent the source of ABC1 in all organs, we used in situ hybridization to localize its expression in human and baboon tissues. Although its presence in macrophages in arterial lesions supports an expected role in the process of atherosclerosis, detection of ABC1 mRNA in liver hepatocytes, villi of the small intestine, tubule cells in the kidney, and cells of the central nervous system serves notice that ABC1 plays a number of roles in lipid transport and homeostasis in addition to the early lipidation of nascent HDL particles in the vascular wall.
|
Methods |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Tissue Preparation
Protocols for obtaining tissue samples were approved by the Emory University Hospital Human Investigation Committee and were in accordance with the principles of the Declaration of Helsinki. Human aorta samples representative of different stages of atherosclerosis were obtained from 9 transplant donors. Human internal mammary arteries (n=2) were used as nonatherosclerotic controls and were obtained from patients undergoing coronary artery bypass surgery. The stages of atherosclerotic development were based on the degree of intimal lesion formation, the presence of inflammatory cells, and regions of necrosis as previously described.12 Normal vessel segments (n=3) had almost no intimal development and no inflammatory cells, as defined by CD68 immunohistochemistry. Atherosclerotic aortas (n=6) had either minor intimal development with scattered macrophage staining just under the luminal surface or were advanced atherosclerotic lesions with a thickened intima, numerous CD-68–positive macrophages in the intima and media, and regions of necrosis and cholesterol deposits. The normal tissue distribution of ABC1 mRNA was determined by using tissues obtained from male baboons, which were collected in the course of other studies. All primate tissues were obtained under protocols approved by the Emory University Institutional Animal Care and Use Committee.
Tissue samples were fixed overnight in 4% (wt/vol) paraformaldehyde in 0.1 mol/L sodium phosphate (pH 7.4) at 4°C and then processed by using standard paraffin techniques. Other tissue samples were collected, immediately immersed in 4% (wt/vol) paraformaldehyde in 0.1 mol/L sodium phosphate (pH 7.4) at 4°C for 3 to 4 hours, cryoprotected in 15% (wt/vol) sucrose/isotonic PBS overnight at 4°C, and processed for frozen sections as previously described. Equivalent in situ hybridization results were obtained with both methods.
In Situ Hybridization
In situ hybridization was performed on paraffin
sections with the use of human-specific
35S-labeled riboprobes as previously
described.13 In situ
hybridization results were photographed by polarized light
epiluminescence microscopy (Leitz) so that the silver grains appeared
white. The results were evaluated by 2 individuals and graded (-, +,
++, and +++) on the basis of the number of cells expressing ABC1 mRNA
in each tissue type.
Probes
A plasmid template for the synthesis of sense and
antisense riboprobes to ABC1 mRNA was constructed by the ligation of
sequences from base pairs 350 to 1805 of the ABC1 cDNA (GenBank
AF285167) into vector pGEM 3Zf- (Promega). RNA probes constituting
either strand of this sequence were synthesized by in vitro
transcription from the T7 or SP6 RNA polymerase promoters flanking the
insert after linearization of the plasmid by restriction digestion.
Probe specificity was confirmed by hybridization of a
32P-labeled probe containing this insert
sequence to Southern blots of human genomic DNA that had been digested
with KpnI,
BamHI, or
EcoRI. Only the bands expected
from restriction enzyme fragment prediction based on the human ABC1
gene sequence (GenBank accession numbers AF287262 and AF287263) were
observed.
Immunohistochemistry
Immunohistochemistry was used on serial sections to
identify cells containing ABC1 mRNA. The following antibodies were
used: CD68 for macrophages (Dako, 1:50 dilution), CD20 for B
cells (Pharmagen, 1:125 dilution), CD3 for T cells (Dako, 1:25
dilution), and SM1 for smooth muscle cell 
-actin (Sigma Chemical Co,
1:800 dilution). Sections were predigested with proteinase K (1 mg/mL,
Sigma) or pronase E (1 mg/mL, Sigma), the primary antibodies were
applied at the indicated dilutions, and the slides were stained by
using ABC-AP (Vector Labs) as
described.14 Serial sections
treated with secondary antibodies only or with nonimmune IgG did not
show any staining.
|
Results |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
The cell types expressing ABC1 mRNA in a series of tissues taken from adult male baboons were determined by in situ hybridization and are summarized in Table 1
. Generally, expression of ABC1 was found in tissues
involved in cholesterol transport and utilization and in
inflammatory cells, including macrophages, T cells, and B
cells.
|
In the liver, ABC1 was expressed in some, but not all,
hepatocytes
(Figure 1). Strong consistent hybridization was seen
in scattered CD68-positive macrophages and Kupffer cells. At
least some of the hybridizing cells in the liver were likely to be B
cells, as determined by serial section immunohistochemistry with the
CD20 antibody (Figure 1, available online at
http://atvb.ahajournals.org). Strong hybridization was found in the
region surrounding the portal vein and appeared to consist of
connective tissue cells and CD68- and CD20-positive lymphocytes found
in this region. The small intestine was found to have numerous
ABC1-positive macrophages in the lamina propria of the
intestinal villi. ABC1 mRNA was not detected in the epithelial cells
lining the small intestine. In the spleen and lymph nodes,
hybridization was found in regions consistent with the
localization of macrophages and B cells. Some hybridization to
T cells was likely in the marginal zone but could not be confirmed. In
the testis, ABC1-positive cells were found in the Leydig cells
surrounding the seminiferous tubules. In the kidney, strong
hybridization that was localized to scattered tissue
macrophages as well as cells lining the proximal and distal
tubules in the cortex and medulla (Figure 2, available online at
http://atvb.ahajournals.org) was found. In a section of the baboon
cerebellum, ABC1 mRNA was detected in glial cells in the white matter
as well as in cells within the granular layer. Purkinje cells did not
express ABC1 mRNA (Figure 3, available online at
http://atvb.ahajournals.org). In the lung, ABC1 was expressed by
pulmonary microphages (Figure 4, available online at http:
//atvb.ahajournals.org).
|
|
|
Normal baboon aorta and carotid artery did not express ABC1
mRNA. Consistent with this result, no ABC1-expressing cells
were found in samples of human internal mammary artery or normal
nonatherosclerotic aortas
(Table 2). Atherosclerotic vessels demonstrated expression
of ABC1 mRNA in scattered lipid-filled macrophages in early
fatty streaks
(Figure 2
) as well as in the shoulder region of advanced
lesions (see http://atvb.ahajournals.org). Nonatherosclerotic regions
of these same vessel cross sections contained no ABC1-hybridizing
cells. In at least 1 vessel, strong hybridization was found in an
inflammatory zone filled with scattered macrophages without
lipids
(Figure 3). In the same tissue section, a portion of the
vessel had a diffuse intimal thickening without inflammatory cells,
which showed no ABC1 hybridization. In all cases, serial section
staining of these vessels with CD68 suggested that ABC1 hybridization
was to macrophages in the atherosclerotic vessels. No
CD20-positive cells were found in the vascular tissues, so it is
unlikely that B cells are the source of ABC1 mRNA; scattered
CD3-positive T cells were present but differed morphologically from
the ABC1-positive cells
(Figures 2 and 3). However, it should be emphasized that not
all CD68-positive macrophages hybridized with the ABC1
riboprobe. ABC1 mRNA was not detected in a number of
non–lipid-associated CD68-positive cells found scattered in other
parts of the vessel, especially in the
adventitia.
|
|
Discussion |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
The genetic basis for understanding the function of ABC1 was its establishment as the defect in the monogenic disorder Tangier disease. These patients have near-zero levels of circulating HDL. Sequence analysis and metabolic and cell culture studies in the last decade have established that apolipoprotein components of HDL are normal in sequence and synthesis in these patients but that HDL is catabolized an increased rate.15 16 Francis et al17 have shown that apolipoprotein-mediated cholesterol efflux is deficient in cells derived from patients with Tangier disease. Hence, the defect in Tangier disease represents an initial step in reverse cholesterol transport. The current understanding is that apolipoproteins or nascent lipid-poor HDL particles fail to acquire a "mature" lipid content and are relatively quickly cleared from the circulation. ABC1 is likely to function as a cell membrane transporter that facilitates the transfer of cholesterol and phospholipids to poorly lipidated apolipoproteins at an exofacial pore, which is ringed by 12 predicted trans-membrane domains.18 Although this may describe the role of ABC1 in resident macrophages coping with excessive cholesterol import, the potential functions of ABC1 in other settings remain unclear. Involvement in activities as diverse as apoptotic cell engulfment and secretion of interleukin-1ß has been proposed,19 20 with the former linked to the calcium-induced exposure of phosphatidylserine at the outer surface of the plasma membrane by a hypothesized "flippase" activity of ABC1.21
Patients with Tangier disease experience cholesterol deposition in many tissues, not only in the enlarged orange tonsils, noted as the hallmark of this disease, but in liver, spleen, intestinal mucosa, lymph nodes, cornea, and Schwann cells.10 22 Major clinical symptoms include not only HDL deficiency and increased incidence of cardiovascular disease but splenomegaly and neuropathy as well. The results in the present study support the role of ABC1 in the development of arterial lesions as well as a broader function in lipid distribution. Previous studies detected the presence of ABC1 message by blot hybridization to whole-organ RNA samples from heart, liver, spleen, kidney, lung, small intestine, and brain.11 23 In situ hybridization data have now confirmed and extended these observations to the level of individual cells within these tissues.
ABC1 RNA is readily detected in fatty macrophages in
early atherosclerotic lesions
(Figure 2). However, not all macrophages in the
plaque specimens are positive. This raises the intriguing issue of the
signals and responses that control its synthesis. Cell culture studies
have demonstrated sterol-induced ABC1 transcription in parallel with
enhancement of cholesterol efflux from such
cells.24 This may be an
adaptive response to maintain cholesterol homeostasis in
cells containing scavenger receptors that allow unregulated uptake of
oxidized or otherwise modified LDL. Cultured THP-1
macrophages show a steady increase of ABC1 RNA during 4 days of
exposure to oxidized LDL.25
It remains to be determined whether some plaque macrophages
fail to express ABC1 as a result of an insufficient signaling input or
a lack of response due to signal overload or because they
represent a unique subclass of macrophages. At this
point, such questions remain unanswered, yet it is suggestive that we
have detected less ABC1 RNA in macrophage-rich regions of
plaques considered to be of an advanced nature. We speculate that these
macrophages may represent foam cells incapable of
ABC1-mediated cholesterol efflux.
A substantial portion of the ABC1 RNA detected in spleen, lung, liver, and small intestine can be attributed to resident macrophages. Splenomegaly with lipid-filled macrophages occurs in some patients with Tangier disease, supporting a role of ABC1 in sterol efflux from macrophages that must cope with a large flux of cholesterol derived from the uptake by the spleen of phagocytic cells and senescent cells.10 Expression of ABC1 in alveolar macrophages in the lung is consistent with a role in lipid homeostasis in these cells that are involved in the uptake and clearance of surfactant phospholipids and cholesterol, as well as diseased and damaged cells.
Much of the expression of ABC1 in liver resides in macrophages and Kupffer cells. However, cells lining the portal vein, B cells, and some hepatocytes are also positive. It can be suggested that in hepatocytes the primary function of ABC1 is to mediate the formation of nascent HDL through the provision of cholesterol and phospholipid to lipid-free apolipoproteins rather than to promote the efflux of excess cholesterol as in macrophages. Such divergent functions may require ABC1 gene regulation to differ in these tissue types. Indeed, Costet et al26 have recently provided evidence that Hep G2 cells produce a variant of ABC1 mRNA that uses a distinct 5' exon, containing a different transcription and translation start site than that expressed in macrophages and cultured fibroblasts.24 26 27 , Because only the initial 22 amino acids of the protein are predicted to differ in the liver form of ABC1,26 potential differences in transcriptional response of the gene may be a more important consequence of the alternatively spliced variants.
ABC1 expression in Leydig cells of the testes implies a role in cholesterol homeostasis in tissues that synthesize steroid hormones, as also noted by the detection of ABC1 message by blot hybridization to adrenal RNA.11 Synthesis of ABC1 in the kidney suggests a role in sterol transport during filtration and reabsorption. Because apoA-I is known to be filtered in the kidney, renal clearance of poorly lipidated apoA-I–containing particles may play a key role in their scarcity in the plasma of patients with Tangier disease and potentially other individuals with low levels of HDL.28 29 The HDL-binding proteins megalin and cubilin are expressed in the kidney and have been proposed to mediate the uptake of apoA-I dissociated from the lipoprotein particle.30 Our detection of ABC1 gene expression in tubules and collecting ducts in the kidney medulla suggest a renal function for ABC1 as well as these other proteins in secreting or recapturing cholesterol and not merely the dissociated protein components of HDL.
It had been suggested that the neuropathology associated with Tangier disease could be linked to the low concentrations of apoA-I and HDL, which could impair the unloading of cholesterol from macrophages and Schwann cells during myelination.10 The detection of ABC1 synthesis in neuronal tissue suggests that this protein plays a direct role in the redistribution of cholesterol and phospholipid in the nervous system, as do other components of lipid transport pathways, such as apoE and members of the LDL receptor family.31
The role of ABC1 in the intestine was not appreciated before the discovery that mice with a targeted disruption of this gene showed an increased absorption of cholesterol from the gut.8 A more recent report of drug-induced increase in ABC1expression and reduction in cholesterol uptake in the mouse intestine supports this activity.32 This suggests that ABC1 acts as a unidirectional transporter to efflux some percentage of absorbed cholesterol back to the intestinal lumen. The cell type and the presumed acceptor apolipoprotein in this process remain to be determined. Although we detect a clear ABC1 RNA signal in intestinal villi, it appears to be uniformly distributed throughout the lamina propria, where it colocalizes with macrophages, not with epithelial cells. Thus, our data may not support a proposed role of ABC1 in cholesterol absorption by the intestine. Alternatively, they may suggest that the "barrier" to absorption may be occurring not in the epithelial layer but in macrophages within the lamina propria. This might be consistent with the report that cultured intestinal epithelioid CaCo2 cells did not show apoA-I–stimulated cholesterol efflux.33 However, until the full nature of the induction of this pathway in the intestine is elucidated, we cannot exclude the possibility that intestinal epithelial cells may not express ABC1 under certain conditions.
The discovery that ABC1 represents the defective gene in Tangier disease and plays a key role in the efflux of cholesterol and phospholipids from macrophages to nascent HDL particles was a key step in clarifying the initiating events in reverse cholesterol transport. Conditions that are known to increase cholesterol efflux from macrophages, including cholesterol loading, cAMP signaling, and treatment with ligands of nuclear hormone receptors, are now known to affect ABC1 transcription in parallel.26 24 33 34 Most cells regulate intracellular cholesterol by controlling its synthesis or its uptake by LDL receptor–mediated endocytosis. Macrophages that ingest cell debris and modified lipoproteins by scavenger receptors that are not downregulated are more dependent on the efflux pathway in which ABC1 may be a rate-limiting component.35 The studies of Chimini and colleagues19 21 add to this the involvement of ABC1 in membrane phospholipid distribution in the process of phagocytosis. However, the distribution of ABC1 gene expression suggests a function beyond that appropriate for phagocytic cells. It can be proposed that ABC1 serves not only to aid in the net efflux of lipids from nonpolarized cells, such as macrophages. It can be hypothesized that in polarized cells lining blood and lymphatic vessels or kidney tubules, ABC1 is involved in the physiological redistribution of lipids via transcytosis, delivering its cargo out of a luminal or basolateral surface. Further definition of all the functions of ABC1 will be gained by the development and use of additional tools, which include genetically manipulated mice, inhibiting antibodies, and selective drugs that alter the quantity or activity of this protein.
|
Acknowledgments |
|---|
This work was support by CV Therapeutics and National Institutes of Health grant HL-58000 (J.N.W.).
Received October 5, 2000; accepted December 5, 2000.
|
References |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
1. Brooks-Wilson A, Marcil M, Clee SM, Zhang LH, Roomp K, van Dam M, Yu L, Brewer C, Collins JA, Molhuizen HO, et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet. 1999;22:336–345.[Medline] [Order article via Infotrieve]
2. Bodzioch M, Orso E, Klucken J, Langmann T, Bottcher A, Diederich W, Drobnik W, Barlage S, Buchler C, Porsch-Ozcurumez M, et al. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet. 1999;22:347–351.[Medline] [Order article via Infotrieve]
3. Rust S, Rosier M, Funke H, Real J, Amoura Z, Piette JC, Deleuze JF, Brewer HB, Duverger N, Denefle P, et al. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet. 1999;22:352–355.[Medline] [Order article via Infotrieve]
4. Lawn RM, Wade DP, Garvin MR, Wang X, Schwartz K, Porter JG, Seilhamer JJ, Vaughan AM, Oram JF. The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. J Clin Invest. 1999;104:R25–R31.
5. Klein I, Sarkadi B, Varadi A. An inventory of the human ABC proteins. Biochim Biophys Acta. 1999;1461:237–262.[Medline] [Order article via Infotrieve]
6.
Wang N, Silver DL,
Costet P, Tall AR. Specific binding of ApoA-I, enhanced
cholesterol efflux and altered plasma membrane morphology
in cells expressing ABC1. J Biol
Chem. 2000;275:33053–33058.
7. Orso E, Broccardo C, Kaminski WE, Bottcher A, Liebisch G, Drobnik W, Gotz A, Chambenoit O, Diederich W, Langmann T, et al. Transport of lipids from Golgi to plasma membrane is defective in Tangier disease patients and ABC1-deficient mice. Nat Genet. 2000;24:192–196.[Medline] [Order article via Infotrieve]
8.
McNeish J, Aiello
RJ, Guyot D, Turi T, Gabel C, Aldinger C, Hoppe KL, Roach ML, Royer LJ,
de Wet J, et al. High density lipoprotein deficiency and foam cell
accumulation in mice with targeted disruption of ATP-binding cassette
transporter-1. Proc Natl Acad Sci
U S A. 2000;97:4245–4250.
9. Marcil M, Brooks-Wilson A, Clee SM, Roomp K, Zhang LH, Yu L, Collins JA, van Dam M, Molhuizen HO, Loubster O, et al. Mutations in the ABC1 gene in familial HDL deficiency with defective cholesterol efflux. Lancet. 1999;354:1341–1346.[Medline] [Order article via Infotrieve]
10. Assmann G, Schmitz G Jr. BHB: familial HDL deficiency: Tangier disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic Basis of Inherited Disease. 6th ed. New York, NY: McGraw-Hill; 1989:1267–1282.
11. Langmann T, Klucken J, Reil M, Liebisch G, Luciani MF, Chimini G, Kaminski WE, Schmitz G. Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages. Biochem Biophys Res Commun. 1999;257:29–33.[Medline] [Order article via Infotrieve]
12.
Wilcox JN,
Subramanian RR, Sundell CL, Tracey WR, Pollock JS, Harrison DG, Marsden
PA. Expression of multiple isoforms of nitric oxide synthase in normal
and atherosclerotic vessels. Arterioscler
Thromb Vasc Biol. 1997;17:2479–2488.
13. Wilcox JN. Fundamental principles of in situ hybridization. J Histochem Cytochem. 1993;41:1725–1733.[Abstract]
14.
Scott NA, Ross CE,
Dunn B, Martin FH, Simonet L, Wilcox JN. Identification of a potential
role for the adventitia in vascular lesion formation after balloon
overstretch injury of porcine coronary arteries.
Circulation. 1996;93:2178–2187.
15. Schaefer EJ, Blum CB, Levy RI, Jenkins LL, Alaupovic P, Foster DM, Brewer HB Jr. Metabolism of high-density lipoprotein apolipoproteins in Tangier disease. N Engl J Med. 1978;299:905–910.[Abstract]
16.
Law SW, Brewer HB
Jr. Tangier disease: the complete mRNA sequence encoding for
preproapo-A-I. J Biol
Chem. 1985;260:12810–12814.
17. Francis GA, Knopp RH, Oram JF. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier disease. J Clin Invest. 1995;96:78–87.
18.
Rosenberg MF,
Callaghan R, Ford RC, Higgins CF. Structure of the multidrug resistance
P-glycoprotein to 2.5 nm resolution determined by electron
microscopy and image analysis.
J Biol Chem. 1997;272:10685–10694.
19. Luciani MF, Chimini G. The ATP binding cassette transporter ABC1, is required for the engulfment of corpses generated by apoptotic cell death. EMBO J. 1996;15:226–235.[Medline] [Order article via Infotrieve]
20.
Hamon Y, Luciani
MF, Becq F, Verrier B, Rubartelli A, Chimini G. Interleukin-1beta
secretion is impaired by inhibitors of the ATP binding
cassette transporter, ABC1.
Blood. 1997;90:2911–2915.
21. Hamon Y, Broccardo C, Chambenoit O, Luciani MF, Toti F, Chaslin S, Freyssinet JM, Devaux PF, McNeish J, Marguet D, et al. ABC1 promotes engulfment of apoptotic cells and transbilayer redistribution of phosphatidylserine. Nat Cell Biol. 2000;2:399–406.[Medline] [Order article via Infotrieve]
22. Serfaty-Lacrosniere C, Civeira F, Lanzberg A, Isaia P, Berg J, Janus ED, Smith MP Jr, Pritchard PH, Frohlich J, Lees RS, et al. Homozygous Tangier disease and cardiovascular disease. Atherosclerosis. 1994;107:85–98.[Medline] [Order article via Infotrieve]
23. Luciani MF, Denizot F, Savary S, Mattei MG, Chimini G. Cloning of two novel ABC transporters mapping on human chromosome 9. Genomics. 1994;21:150–159.[Medline] [Order article via Infotrieve]
24. Schwartz K, Lawn RM, Wade DP. ABC1 gene expression and ApoAI-mediated cholesterol efflux are regulated by LXR. Biochem Biophys Res Commun. 2000;274:794–802.[Medline] [Order article via Infotrieve]
25.
Schiffman D,
Mikita T, Tai JTN, Wade DP, Porter JG, Seilhammer JJ, Somogyi R, Liang
S, Lawn RM. Large scale gene expression analysis of
cholesterol-loaded macrophages.
J Biol Chem. 2000;275:37324–37332.
26.
Costet P, Luo Y,
Wang N, Tall AR. Sterol-dependent transactivation of the ABC1 promoter
by the liver X receptor/retinoid X receptor.
J Biol Chem. 2000;275:28240–28245.
27. Pullinger CR, Hakamata H, Duchateau PN, Eng C, Aouizerat BE, Cho MH, Fielding CJ, Kane JP. Analysis of hABC1 gene 5' end: additional peptide sequence, promoter region, and four polymorphisms. Biochem Biophys Res Commun. 2000;271:451–455.[Medline] [Order article via Infotrieve]
28.
Glass CK, Pittman
RC, Keller GA, Steinberg D. Tissue sites of degradation of apoprotein
A-I in the rat. J Biol
Chem. 1983;258:7161–7167.
29. Horowitz BS, Goldberg IJ, Merab J, Vanni TM, Ramakrishnan R, Ginsberg HN. Increased plasma and renal clearance of an exchangeable pool of apolipoprotein A-I in subjects with low levels of high density lipoprotein cholesterol. J Clin Invest. 1993;91:1743–1752.
30.
Hammad SM, Barth
JL, Knaak C, Argraves WS. Megalin acts in concert with cubilin to
mediate endocytosis of high density lipoproteins.
J Biol Chem. 2000;275:12003–12008.
31.
Ignatius MJ,
Gebicke-Harter PJ, Skene JH, Schilling JW, Weisgraber KH, Mahley RW,
Shooter EM. Expression of apolipoprotein E during nerve degeneration
and regeneration. Proc Natl Acad Sci
U S A. 1986;83:1125–1129.
32.
Repa JJ, Turley
SD, Lobaccaro JM, Medina J, Li L, Lustig K, Shan B, Heyman RA, Dietschy
JM, Mangelsdorf DJ. Regulation of absorption and ABC1-mediated efflux
of cholesterol by RXR heterodimers.
Science. 2000;289:1524–1529.
33.
Bornick AE,
Rothblat GH, Stoudt G, Hoppe KL, Royer LJ, McNeish J, Francone OL. The
correlation of ATP-binding cassette 1 mRNA levels with
cholesterol efflux from various cell lines.
J Biol Chem. 2000;275:28634–28640.
34.
Oram JF, Lawn R,
M., Garvin MR, Wade DP. ABCA1 is the cAMP-inducible apolipoprotein
receptor that mediates cholesterol secretion from
macrophages. J Biol
Chem. 2000;275:34508–34511.
35. Brown MS, Goldstein JL. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu Rev Biochem. 1983;52:223–261. [Medline] [Order article via Infotrieve]
This article has been cited by other articles:
 |
|
 |
|
  P. M. Isoviita, K. Nuotio, J. Saksi, R. Turunen, P. Ijas, J. Pitkaniemi, L. Soinne, M. Kaste, P. T. Kovanen, and P. J. Lindsberg An Imbalance Between CD36 and ABCA1 Protein Expression Favors Lipid Accumulation in Stroke-Prone Ulcerated Carotid Plaques Stroke, February 1, 2010; 41(2): 389 - 393. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. R. Brunham, R. R. Singaraja, M. Duong, J. M. Timmins, C. Fievet, N. Bissada, M. H. Kang, A. Samra, J.-C. Fruchart, B. McManus, et al. Tissue-Specific Roles of ABCA1 Influence Susceptibility to Atherosclerosis Arterioscler Thromb Vasc Biol, April 1, 2009; 29(4): 548 - 554. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Bates, J.-Q. Tao, K. J. Yu, Z. Borok, E. D. Crandall, H. L. Collins, and G. H. Rothblat Expression and Biological Activity of ABCA1 in Alveolar Epithelial Cells Am. J. Respir. Cell Mol. Biol., March 1, 2008; 38(3): 283 - 292. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Smoak, J. Madenspacher, S. Jeyaseelan, B. Williams, D. Dixon, K. R. Poch, J. A. Nick, G. S. Worthen, and M. B. Fessler Effects of Liver X Receptor Agonist Treatment on Pulmonary Inflammation and Host Defense J. Immunol., March 1, 2008; 180(5): 3305 - 3312. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. Jacobs, S. Lingrell, Y. Zhao, G. A. Francis, and D. E. Vance Hepatic CTP:Phosphocholine Cytidylyltransferase-{alpha} Is a Critical Predictor of Plasma High Density Lipoprotein and Very Low Density Lipoprotein J. Biol. Chem., January 25, 2008; 283(4): 2147 - 2155. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Hirsch-Reinshagen, J. Y. Chan, A. Wilkinson, T. Tanaka, J. Fan, G. Ou, L. F. Maia, R. R. Singaraja, M. R. Hayden, and C. L. Wellington Physiologically regulated transgenic ABCA1 does not reduce amyloid burden or amyloid-{beta} peptide levels in vivo J. Lipid Res., April 1, 2007; 48(4): 914 - 923. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. F. Oram and A. M. Vaughan ATP-Binding Cassette Cholesterol Transporters and Cardiovascular Disease Circ. Res., November 10, 2006; 99(10): 1031 - 1043. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-Y. Chen, B.-C. Cheng, M.-J. Jiang, M.-Y. Hsieh, and M.-S. Chang IL-20 Is Expressed in Atherosclerosis Plaques and Promotes Atherosclerosis in Apolipoprotein E-Deficient Mice Arterioscler Thromb Vasc Biol, September 1, 2006; 26(9): 2090 - 2095. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Hirsch-Reinshagen, L. F. Maia, B. L. Burgess, J.-F. Blain, K. E. Naus, S. A. McIsaac, P. F. Parkinson, J. Y. Chan, G. H. Tansley, M. R. Hayden, et al. The Absence of ABCA1 Decreases Soluble ApoE Levels but Does Not Diminish Amyloid Deposition in Two Murine Models of Alzheimer Disease J. Biol. Chem., December 30, 2005; 280(52): 43243 - 43256. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Soumian, R Gibbs, A Davies, and C Albrecht mRNA expression of genes involved in lipid efflux and matrix degradation in occlusive and ectatic atherosclerotic disease J. Clin. Pathol., December 1, 2005; 58(12): 1255 - 1260. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Bates, J.-Q. Tao, H. L. Collins, O. L. Francone, and G. H. Rothblat Pulmonary abnormalities due to ABCA1 deficiency in mice Am J Physiol Lung Cell Mol Physiol, December 1, 2005; 289(6): L980 - L989. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Zhu, H. Liao, X. Xie, Y. Yuan, T.-S. Lee, N. Wang, X. Wang, J. Y.-J. Shyy, and M. B. Stemerman Oxidized LDL downregulates ATP-binding cassette transporter-1 in human vascular endothelial cells via inhibiting liver X receptor (LXR) Cardiovasc Res, December 1, 2005; 68(3): 425 - 432. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Takata, V. Chu, A. R. Collins, C. J. Lyon, W. Wang, F. Blaschke, D. Bruemmer, E. Caglayan, W. Daley, J. Higaki, et al. Transcriptional Repression of ATP-Binding Cassette Transporter A1 Gene in Macrophages: A Novel Atherosclerotic Effect of Angiotensin II Circ. Res., October 28, 2005; 97(9): e88 - e96. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. F. Oram and J. W. Heinecke ATP-Binding Cassette Transporter A1: A Cell Cholesterol Exporter That Protects Against Cardiovascular Disease Physiol Rev, October 1, 2005; 85(4): 1343 - 1372. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Soumian, C Albrecht, A. Davies, and R. Gibbs ABCA1 and atherosclerosis Vascular Medicine, May 1, 2005; 10(2): 109 - 119. [Abstract] [PDF]
|
|
|
|
|
|
C. Albrecht, S. Soumian, J.S. Amey, A. Sardini, C.F. Higgins, A.H. Davies, and R.G.J. Gibbs ABCA1 Expression in Carotid Atherosclerotic Plaques Stroke, December 1, 2004; 35(12): 2801 - 2806. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Ulven, K. T. Dalen, J.-A. Gustafsson, and H. I. Nebb Tissue-specific autoregulation of the LXR{alpha} gene facilitates induction of apoE in mouse adipose tissue J. Lipid Res., November 1, 2004; 45(11): 2052 - 2062. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Hirsch-Reinshagen, S. Zhou, B. L. Burgess, L. Bernier, S. A. McIsaac, J. Y. Chan, G. H. Tansley, J. S. Cohn, M. R. Hayden, and C. L. Wellington Deficiency of ABCA1 Impairs Apolipoprotein E Metabolism in Brain J. Biol. Chem., September 24, 2004; 279(39): 41197 - 41207. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L.-P. Duan, H. H. Wang, and D. Q-H. Wang Cholesterol absorption is mainly regulated by the jejunal and ileal ATP-binding cassette sterol efflux transporters Abcg5 and Abcg8 in mice J. Lipid Res., July 1, 2004; 45(7): 1312 - 1323. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Sahoo, T. C. Trischuk, T. Chan, V. A. B. Drover, S. Ho, G. Chimini, L. B. Agellon, R. Agnihotri, G. A. Francis, and R. Lehner ABCA1-dependent lipid efflux to apolipoprotein A-I mediates HDL particle formation and decreases VLDL secretion from murine hepatocytes J. Lipid Res., June 1, 2004; 45(6): 1122 - 1131. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Selva, V. Hirsch-Reinshagen, B. Burgess, S. Zhou, J. Chan, S. McIsaac, M. R. Hayden, G. L. Hammond, A. W. Vogl, and C. L. Wellington The ATP-binding cassette transporter 1 mediates lipid efflux from Sertoli cells and influences male fertility J. Lipid Res., June 1, 2004; 45(6): 1040 - 1050. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. Bortnick, E. Favari, J.-Q. Tao, O. L. Francone, M. Reilly, Y. Zhang, G. H. Rothblat, and S. R. Bates Identification and characterization of rodent ABCA1 in isolated type II pneumocytes Am J Physiol Lung Cell Mol Physiol, October 1, 2003; 285(4): L869 - L878. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. L. Wellington, L. R. Brunham, S. Zhou, R. R. Singaraja, H. Visscher, A. Gelfer, C. Ross, E. James, G. Liu, M. T. Huber, et al. Alterations of plasma lipids in mice via adenoviral-mediated hepatic overexpression of human ABCA1 J. Lipid Res., August 1, 2003; 44(8): 1470 - 1480. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Desrumaux, P. A. Mak, W. A. Boisvert, D. Masson, D. Stupack, M. Jauhiainen, C. Ehnholm, and L. K. Curtiss Phospholipid transfer protein is present in human atherosclerotic lesions and is expressed by macrophages and foam cells J. Lipid Res., August 1, 2003; 44(8): 1453 - 1461. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Aiello, D. Brees, and O. L. Francone ABCA1-Deficient Mice: Insights Into the Role of Monocyte Lipid Efflux in HDL Formation and Inflammation Arterioscler Thromb Vasc Biol, June 1, 2003; 23(6): 972 - 980. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Joyce, L. Freeman, H. B. Brewer Jr, and S. Santamarina-Fojo Study of ABCA1 Function in Transgenic Mice Arterioscler Thromb Vasc Biol, June 1, 2003; 23(6): 965 - 971. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Kiss, D. C. McManus, V. Franklin, W. L. Tan, A. McKenzie, G. Chimini, and Y. L. Marcel The Lipidation by Hepatocytes of Human Apolipoprotein A-I Occurs by Both ABCA1-dependent and -independent Pathways J. Biol. Chem., March 14, 2003; 278(12): 10119 - 10127. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Fukumoto, A. Deng, M. C. Irizarry, M. L. Fitzgerald, and G. W. Rebeck Induction of the Cholesterol Transporter ABCA1 in Central Nervous System Cells by Liver X Receptor Agonists Increases Secreted Abeta Levels J. Biol. Chem., December 6, 2002; 277(50): 48508 - 48513. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. W. Burgess, R. S. Kiss, H. Zheng, S. Zachariah, and Y. L. Marcel Trypsin-sensitive and Lipid-containing Sites of the Macrophage Extracellular Matrix Bind Apolipoprotein A-I and Participate in ABCA1-dependent Cholesterol Efflux J. Biol. Chem., August 23, 2002; 277(35): 31318 - 31326. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Repa, K. E. Berge, C. Pomajzl, J. A. Richardson, H. Hobbs, and D. J. Mangelsdorf Regulation of ATP-binding Cassette Sterol Transporters ABCG5 and ABCG8 by the Liver X Receptors alpha and beta J. Biol. Chem., May 17, 2002; 277(21): 18793 - 18800. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Liao, T. Langmann, G. Schmitz, and Y. Zhu Native LDL Upregulation of ATP-Binding Cassette Transporter-1 in Human Vascular Endothelial Cells Arterioscler Thromb Vasc Biol, January 1, 2002; 22(1): 127 - 132. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Mikita, G. Porter, R. M. Lawn, and D. Shiffman Oxidized Low Density Lipoprotein Exposure Alters the Transcriptional Response of Macrophages to Inflammatory Stimulus J. Biol. Chem., November 30, 2001; 276(49): 45729 - 45739. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F. Oram and R. M. Lawn ABCA1: the gatekeeper for eliminating excess tissue cholesterol J. Lipid Res., August 1, 2001; 42(8): 1173 - 1179. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Wang, D. L. Silver, C. Thiele, and A. R. Tall ATP-binding Cassette Transporter A1 (ABCA1) Functions as a Cholesterol Efflux Regulatory Protein J. Biol. Chem., June 22, 2001; 276(26): 23742 - 23747. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||